Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Medistim ASA is a Norwegian company specializing in the development and commercialization of medical devices used in cardiac, vascular, and transplant surgery. Its core business focuses on intraoperative blood flow measurement technology, notably through its proprietary products like the VeriQ and MiraQ systems. These systems are crucial for ensuring optimal blood flow during surgeries, thus helping to improve clinical outcomes. Founded in 1984, Medistim is headquartered in Oslo, Norway, and operates with a global network, distributing its products worldwide. The company's strategic strengths lie in its specialized focus on niche surgical applications and its continued innovation in medical technology.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Medistim ASAEli Lilly
Last price
kr 316.00$1,427.28
Currency
NOK
USD
kr 5.7B$1.3T
32.0046.65
kr 9.75$30.81
0.950.39
kr 10.50$6.69
2.56%0.48%
Sector
HealthHealth
Employees
15950,000
Ticker
Nkr MEDI$LLY
Primary listing
XOSLNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in NkrMEDI or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.